You are here:
Dalibor Blažek Research Group
Address: | Kamenice 753/5, 625 00 Brno, Building E35 |
---|
Phone: | +420 549 49 6649 |
---|---|
E-mail: |
Projects
Total number of projects: 3
-
Development and use of CDK11 inhibitors for pilot characterization of the novel anti-cancer target (MUNI/G/1129/2021)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 4/2022 — 12/2024Investor: Masaryk University / Grant Agency of Masaryk University -
DIANA panel for testing of selectivity of inhibitors of clinically relevant protein kinases and its application in the drug discovery market. Preclinical development of new inhibitors of CDK11 - key enzyme for growth of cancer cells. (FW03010138)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2021 — 12/2024Investor: Technology Agency of the Czech Republic / TREND -
Identification and characterization of a new pathway regulating pre-mRNA splicing (GX23-04754X)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2023 — 12/2027Investor: Czech Science Foundation / EXPRO